Venky's (India) Limited has scheduled its 50th Annual General Meeting (AGM) for Tuesday, September 29, 2026. The meeting will be conducted through Video Conferencing or Other Audio Visual Means.

The company notified the National Stock Exchange of India Limited and BSE Limited on September 1, 2026. Shareholders holding equity shares as of the close of business on Friday, September 11, 2026, will be eligible to receive dividends if approved by members during the AGM.

This record date applies to both registered shareholders and beneficial owners whose names appear in depository records. The payout remains subject to member approval at the upcoming general meeting.

Meeting Details

Rohan Bhagwat, Company Secretary and Compliance Officer, issued the notification pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Venky's (India) Limited reported a net profit of ₹49.99 crore for the quarter ended June 30, 2026, marking a 216% year-on-year increase from ₹15.83 crore in the same period last year. The company’s revenue from operations grew 29% to ₹1,118.38 crore, driven by improved volumes and better realizations across its poultry, animal health, and oilseed segments. This robust performance underscores the effectiveness of cost optimization measures despite higher feed prices in the poultry business, significantly boosting shareholder value through expanded margins.

The Board of Directors approved the audited financial results for Q1FY27 in a meeting held on August 11, 2026. The results were reviewed by the Audit Committee and submitted to statutory auditors Sudit K. Parekh & Co. LLP in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial statements were prepared in accordance with Indian Accounting Standard 34 (IND AS 34).

Segment Performance

All three business segments contributed to the top-line growth and profitability:

The Poultry and Poultry Products segment generated revenue of ₹516.89 crore, up from ₹475.66 crore in Q1FY26, with a pre-tax profit of ₹16.25 crore compared to a loss of ₹5.66 crore previously. The improvement was attributed to better volume and realization, offsetting higher feed costs. The Animal Health Products segment saw revenue rise to ₹113.67 crore from ₹96.98 crore, posting a profit of ₹30.31 crore due to higher volume and an improved product mix. The Oilseed segment recorded revenue of ₹527.91 crore, a significant jump from ₹318.02 crore, with profits reaching ₹30.96 crore thanks to cost optimization.

Financial Highlights

Total income stood at ₹1,131.87 crore, while total expenses were ₹1,062.60 crore. Other income decreased slightly to ₹13.49 crore from ₹11.69 crore in the prior year quarter. Finance costs remained controlled at ₹3.94 crore. Earnings per share (basic) were ₹35.49, compared to ₹11.24 in Q1FY26.

What the Numbers Show

The most notable aspect of Venky’s Q1FY27 performance is the divergence between revenue growth and expense management. While revenue grew by nearly 30%, total expenses increased by only 24%, leading to a substantial expansion in operating margins. The Oilseed segment, which now contributes the largest share of revenue (47% of total operations), has become a key profit driver, more than doubling its contribution to pre-tax profits. This shift highlights the company’s successful diversification away from reliance solely on the cyclical poultry business, reducing overall earnings volatility.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE398A01010/f07c52fe-8bf7-4edb-9bf7-8eb3112413ea.pdf